Skip to main content

Move to new side of building

We are excited to announce that Phase 1 of construction will be completed in early March. We will start seeing patients on that side of the clinic the week of March 4th. Monday, March 4th will be a moving day. If you have a scheduled appointment on March 4th you will enter the clinic through our normal front doors. We will have reduced appointments on that day. We will be exclusively in Phase 1 from March through June while the remainder of the clinic undergoes a full renovation.

Here are some changes that will occur from March to June:

• We will be implementing curbside for all appointments and medication or food pick-up. Please call from the parking lot to check in and we will call when a room is ready for you to enter.

• You will enter through a new front entrance into a small makeshift reception area and a staff member will meet you to usher you into an exam room

• Our surgical appointments will be limited for those 3 months. We will still be able to do surgery but have a limited number of cages and recovery areas. Surgical drop-off and pick-up will also be curbside.

• If you purchase food from the clinic, please plan as we will be carrying a reduced volume of food due to lack of storage. You can also visit our online pharmacy and order your food from our online store https://springhillvet.vetsfirstchoice.com/.

Library

Pet Services

  • Degenerative joint disease is arthritis caused by deterioration and degeneration of tissues lining joints. It is an under-recognized condition in cats. Treatment involves modification of the home environment, regular gentle exercise, anti-inflammatory drugs and other medications, omega fatty acids, chondroprotectants, and possibly other nutraceuticals. Maintaining your cat’s weight can help prevent degenerative joint disease.

  • Degenerative joint disease is arthritis caused by deterioration and degeneration of tissues lining joints. Treatment includes regular gentle exercise, anti-inflammatory drugs and other medications, omega fatty acids, chondroprotectants, and possibly other nutraceuticals. Emerging therapies include rehabilitation therapy, acupuncture, and stem cell or platelet rich plasma therapies. Maintaining your dog’s weight can help prevent degenerative joint disease.

  • Degenerative myelopathy (DM), a disease affecting the spinal cord, results in slowly progressive hind limb weakness and paralysis. It is considered a disease of middle-aged to older dogs, including German shepherds, German shepherd crosses, Siberian huskies, and collies. It will be suspected based on breed, medical history, physical examination, and diagnostic tests. Unfortunately, there is no effective treatment, and it is a progressive, incurable disease.

  • Demodectic mange is caused by a parasitic mite that lives in the hair follicles of dogs. As long as the body's immune system is functioning properly, these mites cause no harm. Demodectic mange most often occurs when a dog has an immature or weakened immune system, allowing the number of skin mites to increase rapidly. Topical, oral, and injectable medications are available to treat demodectic mange.

  • If a tooth is unerupted, it is at risk of forming a destructive dentigerous (odontogenic) cyst in the bone. Although unerupted or broken teeth can be painful, dogs rarely show obvious signs of pain. Dentigerous cysts, including and the original tooth must be removed carefully as to avoid compromising the bone, which can easily fracture during the extraction. Dentigerous cysts are preventable if unerupted teeth are addressed early in life.

  • Dermatomyositis is hereditary, immune-mediated disease of the skin muscles and blood vessels affecting primarily collies, Shetland Sheepdogs and mixes of these breeds. Other breeds can experience similar disease. Signs are usually first recognized in puppies but can present in young adulthood. Signs include: skin lesions (crusty erosions, patchy alopecia or ulcers) around the eyes, lips, face, ear flaps or tail tip, foot pad lesions; atrophy of chewing muscles or difficulty chewing; stiff gait and megaesophagus in severely affected dogs. Skin biopsies are diagnostic. Treatment involves treating secondary bacterial infections, reducing sun exposure, EFAs, and immunomodulatory medications including tetracycline, niacinamide, pentoxifylline, cyclosporine and corticosteroids. Prognosis varies depending on severity.

  • This handout discusses the growing trend for designer dog breeds – the crossing of pure dog breeds to create dogs that combine “the best of both worlds.” The pros and cons of this practice are highlighted, along with some of the more common designer breeds currently available.

  • Dexmedetomidine is a sedative/tranquilizer used primarily in cats and dogs as a pre-medication injection for anesthesia or for chemical restraint. It is also used orally in dogs for short-term anxiety management. The most common side effect is a low heart rate. Dexmedetomidine should not be used in patients with severe heart liver or kidney disease. It should be used cautiously in young, old, or weak animals. Consult your veterinary office immediately if you suspect a negative reaction or overdose.

  • Diabetes insipidus is rare in cats and is characterized by excessive drinking and the production of enormous volumes of extremely dilute urine. Despite drinking large volumes of water, the cat can become dehydrated from urinating so much. Increased drinking and urination are common signs of several other health conditions, so it is essential that several diagnostic tests be performed to diagnose diabetes insipidus. While the condition is rarely curable, it is usually successfully controlled.

  • Diabetes insipidus results in excessive drinking and urination. As many conditions cause these signs, a number of diagnostic tests including bloodwork and urinalysis need to be performed to rule out other causes. After more common causes are ruled out, a modified water deprivation test can confirm disease and an MRI or therapeutic trial can be performed. Diabetes insipidus results from reduced production of ADH from the brain or reduced sensitivity to ADH in the kidney. Treatment depends on the cause of the disease either replacing the lack of ADH with a synthetic replacement or using a hydrochlorothiazide and a low salt diet to decrease urine production.